Skip to content

US · VANI · BIOTECHNOLOGY

Vivani Medical, Inc. (VANI) intrinsic value and stock valuation

$1.14as of 2026-11-21 · Mkt cap 119M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Vivani Medical, Inc. DCF and intrinsic value

InvestorsCraft values VANI with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from VANI’s statements →

Vivani Medical, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Biotechnology Alameda, CA 94502 vivani.com

How the business is doing

Fiscal 2012–2025, USD

Revenue
$0.00
20122025
Net income
-$-26.61M
20122025
Free cash flow
-$-25.49M
20122025
Total equity
$15.7M+51.8% 5y CAGRd
20122025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2012–2025, USD
20252024202320222021
Revenue$0.00$0.00$0.00$0.00$0.00
Operating income-$-27.56M-$-24.68M-$-26.96M-$-21.24M-$-13.32M
Net income-$-26.61M-$-23.49M-$-25.65M-$-13.89M-$-12.77M
EPSd-$-426.51K-$-427.25K-$-504.42K-$-363.23K-$-352.28K
Operating cash flow-$-24.32M-$-20.79M-$-23.7M-$-18.79M-$-10.95M
Capital expenditure-$-1.17M-$-560K-$-890K-$-340K-$-570K
Free cash flow-$-25.49M-$-21.34M-$-24.59M-$-19.12M-$-11.52M
Total assets$39.4M$41.6M$45.8M$51.1M$5.45M
Total debt$18.9M$19.3M$20.7M$950K$1.81M
Net debt$2.62M$960K$40K-$-44.12M-$-370K
Total equity$15.7M$17.6M$20.8M$44.3M$2.46M
Cash and short-term investments$16.2M$18.4M$20.7M$45.1M$2.18M
Income statement
20252024202320222021
Revenue$0.00$0.00$0.00$0.00$0.00
Cost of revenue$420K$0.00$360K$0.00$0.00
Gross profit-$-420K$0.00-$-360K$0.00$0.00
Research and development expenses$18.1M$15.7M$17M$14.2M$11M
Selling, general and administrative expenses$9.43M$8.93M$10M$5.37M$2.32M
Other expenses-$-420K$0.00-$-360K$1.7M$0.00
Operating expenses$27.1M$24.7M$26.6M$21.2M$13.3M
Cost and expenses$27.6M$24.7M$27M$21.2M$13.3M
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$0.00$0.00$0.00$0.00$0.00
Depreciation and amortization$420K$400K$360K$380K$340K
Ebitda-$-26.18M-$-23.09M-$-25.3M-$-19.16M-$-12.43M
Operating income-$-27.56M-$-24.68M-$-26.96M-$-21.24M-$-13.32M
Total other income/expenses, net$950K$1.19M$1.31M$7.35M$550K
Income before tax-$-26.61M-$-23.49M-$-25.65M-$-13.89M-$-12.77M
Income tax expense$0.00$0.00$0.00$0.00$0.00
Net income-$-26.61M-$-23.49M-$-25.65M-$-13.89M-$-12.77M
Weighted average shares outstanding$62.4M$55M$50.9M$38.2M$36.3M
Weighted average diluted shares outstanding$62.4M$55M$50.9M$38.2M$36.3M
Balance sheet
20252024202320222021
Cash and short-term investments$16.2M$18.4M$20.7M$45.1M$2.18M
Net receivables$650K$250K$0.00$0.00$0.00
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$17.9M$20.4M$23.1M$47.5M$2.47M
Property, plant and equipment, net$20.1M$19.7M$21.3M$1.96M$2.78M
Goodwill and intangible assets$0.00$0.00$0.00$0.00$0.00
Long-term investments$1.34M$1.34M$1.34M$0.00$0.00
Total non-current assets$21.5M$21.1M$22.7M$3.6M$2.98M
Total assets$39.4M$41.6M$45.8M$51.1M$5.45M
Accounts payable$1.03M$820K$540K$1.18M$280K
Short-term debt$1.79M$1.35M$1.38M$950K$910K
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$6.6M$5.99M$5.72M$6.82M$2.09M
Long-term debt$17.1M$18M$19.3M$0.00$900K
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$17.1M$18M$19.3M$0.00$900K
Capital lease obligations$1.79M$19.3M$20.7M$950K$1.81M
Total liabilities$23.7M$24M$25M$6.82M$2.99M
Common stock$10K$10K$10K$10K$54.7M
Retained earnings-$-148.53M-$-121.92M-$-98.44M-$-72.79M-$-58.9M
Accumulated other comprehensive income (loss)$30K$50K$140K$40K$0.00
Total equity$15.7M$17.6M$20.8M$44.3M$2.46M
Total investments$1.34M$1.34M$1.34M$0.00$0.00
Total debt$18.9M$19.3M$20.7M$950K$1.81M
Net debt$2.62M$960K$40K-$-44.12M-$-370K
Cash flow statement
20252024202320222021
Net income-$-26.61M-$-23.49M-$-25.65M-$-13.89M-$-12.77M
Depreciation and amortization$420K$400K$360K$380K$340K
Stock-based compensation$1.48M$1.61M$1.86M$1.3M$1.67M
Change in working capital$230K$350K-$-1.29M$340K$440K
Accounts receivable-$-400K$0.00$0.00$0.00$0.00
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable-$-220K$250K-$-600K-$-1.94M$10K
Net cash provided by operating activities-$-24.32M-$-20.79M-$-23.7M-$-18.79M-$-10.95M
Investments in property, plant and equipment-$-1.17M-$-560K-$-890K-$-340K-$-570K
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities-$-1.17M-$-560K-$-890K-$-340K-$-570K
Common stock issued$23.3M$18.8M$130K$20K$11.6M
Common stock repurchased-$-30K$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$23.3M$19.1M$130K$63.4M$11.6M
Net change in cash-$-2.12M-$-2.3M-$-24.45M$44.3M$100K
Cash at end of period$17.6M$19.7M$22M$46.4M$2.18M
Operating cash flow-$-24.32M-$-20.79M-$-23.7M-$-18.79M-$-10.95M
Capital expenditure-$-1.17M-$-560K-$-890K-$-340K-$-570K
Free cash flow-$-25.49M-$-21.34M-$-24.59M-$-19.12M-$-11.52M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Vivani Medical, Inc.

        Vivani Medical, Inc. is a clinical-stage biopharmaceutical company that specializes in developing innovative implantable medical devices. The firm aims to address chronic diseases for which current treatments are insufficient or lacking. Its key initiatives include a portfolio of miniature drug implants, designed to ensure consistent and stable therapeutic drug delivery, as well as advanced implantable visual prostheses intended to provide meaningful artificial vision to blind individuals. Vivani Medical is headquartered in Emeryville, California.

        CEO
        Adam Mendelsohn
        Employees
        42
        Beta
        3.29

        Explore

        Frequently asked questions

        What is the intrinsic value of Vivani Medical, Inc. (VANI)?

        InvestorsCraft does not currently publish an intrinsic value for VANI. How the IC value is calculated.

        Is VANI undervalued?

        InvestorsCraft does not publish an undervaluation signal for VANI at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.